Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens. We are rapidly developing a pipeline of medicines targeted to the specific molecular dysregulations underlying severe autoimmune conditions, unlocking new treatment options for patients who are underserved by existing therapies.
External link for Priovant Therapeutics
Durham, NC 27703, US
Priovant Therapeutics reposted this
We're thrilled to share the results of the successful Phase 3 VALOR study of brepocitinib in dermatomyositis. This is an exciting moment for the DM community and we are deeply grateful to all the patients and investigators who made it possible. https://lnkd.in/ecu7Wz-F
We're thrilled to share the results of the successful Phase 3 VALOR study of brepocitinib in dermatomyositis. This is an exciting moment for the DM community and we are deeply grateful to all the patients and investigators who made it possible. https://lnkd.in/ecu7Wz-F